Drug data last refreshed 1h ago · AI intelligence enriched 1h ago
PANDEL is a topical hydrocortisone probutate cream, a mild-to-moderate potency corticosteroid indicated for inflammatory and pruritic dermatological conditions. It penetrates the skin to reduce inflammation, itching, and redness in conditions such as eczema, psoriasis, and dermatitis. The drug works through classic glucocorticoid receptor binding to suppress immune-mediated skin inflammation.
This mature topical steroid faces LOE pressure with minimal Part D spending, suggesting a small commercial team focused on defensive positioning and cost management rather than growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PANDEL offers limited growth trajectory given its LOE-approaching status and minimal commercial spending; career value lies in defensive strategy execution, market access navigation, and understanding post-LOE product management. Roles are typically smaller teams focused on profitability maintenance and generic transition planning rather than launch excitement or market expansion.
Worked on PANDEL at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo